The peroxisome proliferator-activated receptor α L162V mutation is associated with reduced adiposity

Obesity Research

Volumn 11, Issue 7, 2003, Pages 809-816

  Bossé, Yohan ^a   Després, Jean Pierre ^a,b   Bouchard, Claude ^c   Pérusse, Louis ^a   Vohl, Marie Claude ^a,d  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

Fat mass; Missense mutation; Nuclear receptor; Population risk

Indexed keywords

CELL RECEPTOR; DNA; TRANSCRIPTION FACTOR;

ABDOMEN; ADIPOSE TISSUE; ADULT; ALLELE; ARTICLE; BODY COMPOSITION; BODY CONSTITUTION; BODY MASS; BODY WEIGHT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION;

ABDOMEN; ADIPOSE TISSUE; ADULT; ALLELES; BODY COMPOSITION; BODY CONSTITUTION; BODY MASS INDEX; BODY WEIGHT; DNA; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRIPTION FACTORS;

EID: 0142093597     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.112     Document Type: Article

References (37)

1. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 1994;272:205-11.
2. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998;22:39-47.
3. Thompson D, Brown JB, Nichols GA, Elmer PJ, Oster G. Body mass index and future healthcare costs: a retrospective cohort study. Obes Res. 2001;9:210-8.
4. Perusse L, Chagnon YC, Weisnagel SJ, et al. The human obesity gene map: the 2000 update. Obes Res. 2001;9:135-69.
5. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26:76-80.
6. Nuclear Receptors Nomenclature Committee, 1999. A unified nomenclature system for the nuclear receptor superfamily. Cell. 1999;97:161-3.
7. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835-9.
8. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology. 1996;137:354-66.
9. Auboeuf D, Rieusset J, Fajas L, et al. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes. 1997;46:1319-27.
10. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990;347:645-50.
11. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA. 1997;94:4312-7.
12. Kliewer SA, Sundseth SS, Jones SA, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA. 1997;94:4318-23.
13. Krey G, Braissant O, L'Horset F et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol. 1997;11:779-91.
14. Schoonjans K, Martin G, Staels B, Auwerx J. Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol. 1997;8:159-66.
15. Fruchart JC, Duriez P, Staels B. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr Opin Lipidol. 1999;10:245-57.
16. Pineda Torra I, Gervois P, Staels B. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Curr Opin Lipidol. 1999;10:151-9.
17. Aoyama T, Peters JM, Iritani N, et al. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem. 1998;273:5678-84.
18. Guerre-Millo M, Gervois P, Raspe E, et al. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem. 2000;275:16638-42.
19. Mancini FP, Lanni A, Sabatino L, et al. Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats. FEBS Lett. 2001;491:154-8.
20. Chaput E, Saladin R, Silvestre M, Edgar AD. Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight. Biochem Biophys Res Commun. 2000;271:445-50.
21. Costet P, Legendre C, More J, Edgar A, Galtier P, Pineau T. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem. 1998;273:29577-85.
22. Vohl MC, Lepage P, Gaudet D, et al. Molecular scanning of the human PPARa gene: association of the L162v mutation with hyperapobetalipoproteinemia. J Lipid Res. 2000;41:945-52.
23. Flavell DM, Pineda Torra I, Jamshidi Y, et al. Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in type II diabetic subjects. Diabetologia. 2000;43:673-80.
24. Sapone A, Peters JM, Sakai S, et al. The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants. Pharmacogenetics. 2000;10:321-33.
25. Bouchard C. Genetic epidemiology, association, and sib-pair linkage: results from the Quebec Family Study. In: Bray GA, Ryan DH, eds. Molecular and Genetic Aspects of Obesity. Baton Rouge, LA: Louisiana State University Press; 1996, pp. 47-81.
26. Lohman T, Roche AF, Martorell R. Standardization of Anthropometric Measurements. Champaign, IL: Human Kinetics; 1988.
27. Behnke AR, Wilmore JH. Evaluation and Regulation of Body Build and Composition. Englewood Cliffs, NJ: Prentice-Hall; 1974.
28. Meneely GR, Kaltreider NL. Volume of the lung determined by helium dilution. J Clin Invest. 1949;28:129-39.
29. Siri WE. The gross composition of the body. Adv Biol Med Phys. 1956;4:239-80.
30. Despres JP, Prud'homme D, Pouliot MC, Tremblay A, Bouchard C. Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr. 1991;54:471-7.
31. Galli A, Pinaire J, Fischer M, Dorris R, Crabb DW. The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism: a novel mechanism for the development of ethanol-induced fatty liver. J Biol Chem. 2001;276:68-75.
32. Lacquemant C, Lepretre F, Pineda Torra I, et al. Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease. Diabetes Metab. 2000;26:393-401.
33. Evans D, Aberle J, Wendt D, Wolf A, Beisiegel U, Mann WA. A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus. J Mol Med. 2001;79:198-204.
34. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998;98:2088-93.
35. Akiyama TE, Nicol CJ, Fievet C, et al. Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines. J Biol Chem. 2001;276:39088-93.
36. Peters JM, Park Y, Gonzalez FJ, Pariza MW. Influence of conjugated linoleic acid on body composition and target gene expression in peroxisome proliferator-activated receptor alpha-null mice. Biochim Biophys Acta. 2001;1533:233-42.
37. Freely associating. Nat Genet. 1999;22:1-2.